Rationale for triple fixed-dose combination therapy with an angiotensin II receptor blocker, a calcium channel blocker, and a thiazide diuretic

Hypertension is a growing global health problem, and is predicted to affect 1.56 billion people by 2025. Treatment remains suboptimal, with control of blood pressure achieved in only 20%–35% of patients, and the majority requiring two or more antihypertensive drugs to achieve recommended blood press...

Descripción completa

Detalles Bibliográficos
Autores principales: Volpe, Massimo, Tocci, Giuliano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2012
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3383291/
https://www.ncbi.nlm.nih.gov/pubmed/22745561
http://dx.doi.org/10.2147/VHRM.S28359

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3383291/
https://www.ncbi.nlm.nih.gov/pubmed/22745561
http://dx.doi.org/10.2147/VHRM.S28359

Ejemplares similares